Multiplex technologies to advance immuno-oncology and oncology discoveries

​​Webinar objectives 

• Discuss key technology and technical hurdles for personalised medicine in immuno-oncology
• Review method for fluorescent multiplex immunostaining and related digital image analysis
• Discover how multiplexed imaging can be used to infer organization of immune cells in human tumors
  ​

​Abcam is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.  Interested in receiving P.A.C.E credit for this educational session? Request credit here!

Speakers

• Joe Yeong, A*STAR, Singapore
  • The era beyond PD-L1: What can we do to help oncologists colleagues and patients further for personalized medicine?
  • Timestamp: 8:20 - 38:57
• Leeat Keren, Weizmann Institute of Science, Israel
  • Love thy neighbor – unraveling the tumor-immune microenvironment using multiplexed imaging
  • Timestamp: 39:57 - 59:50
• Jacques Fieschi, HalioDx, France
  • Bridging translation research to clinical application: Brightplex, a validated multiplex IHC technology to spatially explore the TME
  • Timestamp: 1:00:37 - 1:25:23
• Adrien Guillot, Charité - Universitätsmedizin Berlin, Germany
  • Multiplex immunohistochemistry on a single archival formalin-fixed paraffin-embedded tissue section
  • Timestamp: 1:26:30 - 1:47:08